Please login to the form below
Bio Products Laboratory
This page shows the latest Bio Products Laboratory news and features for those working in and with pharma, biotech and healthcare.
CHMP backs orphan drugs Uptravi and Coagadex
EMA advisors set Actelion and Bio Products therapies on path to European approval. ... The panel backed Coagudex (factor X concentrate) from Bio Products Laboratory for the treatment of factor X deficiency, a rare inherited bleeding disorder, along with
Latest news
-
BPL bags FDA approval for rare bleeding disorder therapy
First drug approved for hereditary Factor X deficiency. UK firm Bio Products Laboratory (BPL) has won US approval for Coagadex, the first drug approved specifically for patients with the rare bleeding
-
PMEA 2005: Winners in pictures
Innovation Award. Winners: Dermatology by Medlock Medical (submitted by The Foundry Communications) &Subgam - The Butterfly Club by Bio Products Laboratory.
-
Communiqué Awards 2005: Results
Agency: Athena Medical PR. Client: Bio Products Laboratory. Campaign: Subgam - The Butterfly Club. ... Client: Bio Products Laboratory. Campaign: The Launch of Subgam. Agency: Virgo Health PR.
-
Communiqué Awards 2007: Results
Finalist:. Agency:Oyster Healthcare Communications. Client:Bio Products Laboratory. Campaign:Immunotherapeutics Quarterly (IQ) magazine. ... Client:Roche Products. Campaign:Finding a clear and consistent voice on pandemic influenza. . . . .
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Project Manager/ Account Manager
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Welcome to the Communique Awards - Communiqué Awards 2018
- ‘Inflexible’ NICE blocking access to rare disease drugs
- 2019: CRISPR and therapeutic gene editing comes of age
- GW Pharma's cannabis-based medicine to be tested in dementia
- More good news, and some bad, for Merck’s Keytruda
- BioMarin prepares for haemophilia A gene therapy data readout, filing
- Innovent gears up for PD-1 inhibitor launch in China
- NICE knocks back BioMarin’s Batten disease drug
- Amgen, Servier start second phase 3 trial of heart failure hope
- The importance of co-creation with patients
- McCann Health's next challenge: creative differentiation
PMHub
Wordbird
Wordbird is a healthcare communications agency with creative, compelling copy at its heart....
Latest intelligence
- The importance of co-creation with patients
- Overcoming the barriers...
- Three billboards on the road to multichannel
- Chris Ross examines the trends driving multichannel communication in 2019...
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
